Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Atosiban versus placebo in the treatment of threatened preterm birth between 30 and 34 weeks gestation: study protocol of the 4-year APOSTEL 8 follow-up.
van der Windt L, Klumper J, van Limburg Stirum EVJ, van 't Hooft J, van Wely M, van Wassenaer-Leemhuis AG, Pajkrt E, Oudijk MA; APOSTEL 8 Study Group. van der Windt L, et al. Among authors: van wassenaer leemhuis ag. BMJ Open. 2024 Jul 18;14(7):e083600. doi: 10.1136/bmjopen-2023-083600. BMJ Open. 2024. PMID: 39025819 Free PMC article.
Association between bronchopulmonary dysplasia severity and its risk factors and long-term outcomes in three definitions: a historical cohort study.
Katz TA, van Kaam AH, Zuithoff NPA, Mugie SM, Beuger S, Blok GJ, van Kempen AAMW, van Laerhoven H, Lutterman CAM, Rijpert M, Schiering IA, Ran NC, Visser F, van Straaten E, Aarnoudse-Moens CSH, van Wassenaer-Leemhuis AG, Onland W. Katz TA, et al. Among authors: van wassenaer leemhuis ag. Arch Dis Child Fetal Neonatal Ed. 2024 Dec 20;110(1):51-56. doi: 10.1136/archdischild-2024-326931. Arch Dis Child Fetal Neonatal Ed. 2024. PMID: 38897634 Free PMC article.
Effect of systemic hydrocortisone in ventilated preterm infants on parent-reported behavioural outcomes at 2 years' corrected age: follow-up of a randomised clinical trial.
Halbmeijer NM, Onland W, Cools F, Swarte RM, van der Heide-Jalving M, Dijk P, Mulder-de Tollenaer S, Tan RNGB, Mohns T, Bruneel E, van Heijst AFJ, Kramer B, Debeer A, van Weissenbruch MM, Marechal Y, Blom H, Plaskie K, Offringa M, van Wassenaer-Leemhuis AG, van Kaam AH, Aarnoudse-Moens CSH; SToP-BPD study group. Halbmeijer NM, et al. Among authors: van wassenaer leemhuis ag. Arch Dis Child Fetal Neonatal Ed. 2023 Jul;108(4):373-379. doi: 10.1136/archdischild-2022-324179. Epub 2023 Jan 2. Arch Dis Child Fetal Neonatal Ed. 2023. PMID: 36593110 Clinical Trial.
Long-term follow-up of children exposed in-utero to progesterone treatment for prevention of preterm birth: study protocol of the AMPHIA follow-up.
Simons NE, van Limburg Stirum EVJ, van Wassenaer-Leemhuis AG, Finken MJJ, Aarnoudse-Moens CSH, Oosterlaan J, van Baar A, Roseboom TJ, Lim AC, van Wely M, de Boer MA, Painter RC, Pajkrt E, Oudijk MA, van T Hooft J; AMPHIA study group. Simons NE, et al. Among authors: van wassenaer leemhuis ag. BMJ Open. 2021 Sep 21;11(9):e053066. doi: 10.1136/bmjopen-2021-053066. BMJ Open. 2021. PMID: 34548367 Free PMC article.
Maternal, perinatal and childhood outcomes of the PPROMEXIL-III cohort: Pregnancies complicated by previable prelabor rupture of membranes.
Simons NE, de Ruigh AA, van der Windt LI, Kazemier BM, van Wassenaer-Leemhuis AG, van Teeffelen AS, van Leeuwen E, Mol BW, van 't Hooft J, Pajkrt E. Simons NE, et al. Among authors: van wassenaer leemhuis ag. Eur J Obstet Gynecol Reprod Biol. 2021 Oct;265:44-53. doi: 10.1016/j.ejogrb.2021.08.007. Epub 2021 Aug 8. Eur J Obstet Gynecol Reprod Biol. 2021. PMID: 34428686 Free article.
Child outcomes after induction of labour or expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks of gestation: study protocol of the PPROMEXIL Follow-up trial. A long-term follow-up study of the randomised controlled trials PPROMEXIL and PPROMEXIL-2.
de Ruigh AA, Simons NE, Van 't Hooft J, van Wassenaer-Leemhuis AG, Aarnoudse-Moens CSH, van Wely M, van Baaren GJ, Vlemmix F, van der Ham DP, van Teeffelen ASP, Mol BW, Roseboom TJ, Pajkrt E. de Ruigh AA, et al. Among authors: van wassenaer leemhuis ag. BMJ Open. 2021 Jun 15;11(6):e046046. doi: 10.1136/bmjopen-2020-046046. BMJ Open. 2021. PMID: 34130959 Free PMC article.
Development and nationwide implementation of a postdischarge responsive parenting intervention program for very preterm born children: The TOP program.
Jeukens-Visser M, Koldewijn K, van Wassenaer-Leemhuis AG, Flierman M, Nollet F, Wolf MJ. Jeukens-Visser M, et al. Among authors: van wassenaer leemhuis ag. Infant Ment Health J. 2021 May;42(3):423-437. doi: 10.1002/imhj.21902. Epub 2020 Dec 18. Infant Ment Health J. 2021. PMID: 33336859 Free PMC article.
Temporizing management vs immediate delivery in early-onset severe preeclampsia between 28 and 34 weeks of gestation (TOTEM study): An open-label randomized controlled trial.
Duvekot JJ, Duijnhoven RG, van Horen E, Bax CJ, Bloemenkamp KW, Brussé IA, Dijk PH, Franssen MT, Franx A, Oudijk MA, Porath MM, Scheepers HC, van Wassenaer-Leemhuis AG, van Drongelen J, Mol BW, Ganzevoort W; TOTEM study collaboration group. Duvekot JJ, et al. Among authors: van wassenaer leemhuis ag. Acta Obstet Gynecol Scand. 2021 Jan;100(1):109-118. doi: 10.1111/aogs.13976. Epub 2020 Aug 28. Acta Obstet Gynecol Scand. 2021. PMID: 33319930 Free PMC article. Clinical Trial.
66 results